文献速递眼底病与葡萄膜炎青光眼

Mettl3介导的N6-甲基腺苷修饰通过抑制FoxO1介导的自噬减轻视网膜缺血再灌注损伤中的神经节细胞丢失和视网膜功能障碍

Mettl3-Mediated N6-Methyladenosine Modification Mitigates Ganglion Cell Loss and Retinal Dysfunction in Retinal Ischemia-Reperfusion Injury by Inhibiting FoxO1-Mediated Autophagy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究在雄性C57BL/6J小鼠中诱导视网膜缺血再灌注损伤,探究m6A修饰和自噬的作用。结果显示抑制自噬可减轻RGC丢失并保护视网膜电生理功能;Mettl3过表达通过上调FoxO1 mRNA的m6A修饰抑制自噬、降低FoxO1表达,从而改善RGC存活和视网膜功能。

要点

  • 抑制自噬可改善RIR损伤中的RGC存活和视网膜电生理功能。
  • RIR损伤小鼠中Mettl3介导的m6A修饰水平下降。
  • 玻璃体内注射过表达Mettl3可减轻RGC丢失和视网膜电生理功能障碍。

核心结论

  • Mettl3介导的m6A修饰通过抑制FoxO1介导的自噬减轻RIR损伤中的RGC丢失和视网膜电生理功能障碍。

研究设计与样本

  • 使用6-8周龄雄性野生型C57BL/6J小鼠诱导视网膜缺血再灌注损伤模型。
  • 通过视网膜铺片免疫荧光评估RGC存活率,通过视网膜电图和视动反应评估视网膜电生理功能和视力。
  • 通过蛋白质印迹和透射电镜图像反映自噬水平,通过m6A斑点印迹测定m6A修饰水平。
  • 通过甲基化RNA免疫沉淀-定量PCR检测FoxO1 mRNA上的m6A修饰水平。
  • 使用3-甲基腺嘌呤和雷帕霉素调节RIR损伤中的自噬水平。

主要发现

  • 抑制自噬可改善RIR损伤中的RGC丢失并保护视网膜电生理功能。
  • RIR损伤小鼠中观察到Mettl3介导的m6A修饰降低。
  • 在RIR损伤前通过玻璃体内注射2型重组腺相关病毒过表达Mettl3,可改善RIR损伤诱导的RGC丢失和视网膜电生理功能障碍。
  • Mettl3过表达通过上调FoxO1 mRNA上的m6A修饰抑制自噬并降低FoxO1表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: N6-methyladenosine (m6A) modification has been implicated in ischemia-reperfusion injury in various systems and in several neurodegenerative diseases. Glaucoma is characterized by degeneration of retinal ganglion cells (RGCs) and shares similar pathologic injury characteristics with retinal ischemia-reperfusion (RIR) injury. However, the specific role of m6A modification in RIR injury is unclear, and the involvement of autophagy in RIR injury also remains controversial. Therefore, our study explored the role of m6A modification and autophagy in RIR injury. METHODS: Male wild-type C57BL/6J mice (6-8 weeks old) were used to induce RIR injury. Retinal flat-mount immunofluorescence was performed to assess RGC survival rate. Electroretinogram and optomotor response were conducted to evaluate the retinal electrophysiologic function and visual acuity. Autophagy level was reflected by Western blot and transmission electron microscope images. M6A modification levels were determined via m6A dot blot. Methyltransferase-like protein 3 (Mettl3) and forkhead box O1 (FoxO1) protein expressions were tested by Western blot. Methylated RNA immunoprecipitation-quantitative PCR was conducted to examine m6A modification level on FoxO1 mRNA. We also employed 3-methyladenine and rapamycin to regulate autophagy level in RIR injury. RESULTS: Inhibiting autophagy ameliorated RGC loss and preserved retinal electrophysiologic function in RIR injury. Additionally, a decrease in Mettl3-mediated m6A modification was observed in RIR injury mice. By overexpressing Mettl3 via intravitreal injection of type 2 recombinant adeno-associated virus before RIR injury, we established that Mettl3 overexpression can also ameliorate RGC loss and retinal electrophysiologic dysfunction induced by RIR injury. Furthermore, Mettl3 overexpression inhibited autophagy and reduced FoxO1 expression by upregulating m6A modifications on FoxO1 mRNA. CONCLUSIONS: Mettl3-mediated m6A modification mitigates RGC loss and retinal electrophysiologic dysfunction by inhibiting FoxO1-mediated autophagy in RIR injury.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhu F, Feng J, Pan Y, et al. Mettl3-Mediated N6-Methyladenosine Modification Mitigates Ganglion Cell Loss and Retinal Dysfunction in Retinal Ischemia-Reperfusion Injury by Inhibiting FoxO1-Mediated Autophagy. Invest Ophthalmol Vis Sci. 2025. PMID: 39982709. doi:10.1167/iovs.66.2.58

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。